Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study.
Christian FriedrichKlaus FranckeIsabella GashawChristian ScheeransStefan KleinLueder FelsJaclyn Ann SmithThomas HummelAlyn Hugh MoricePublished in: Clinical pharmacokinetics (2022)
Clinicaltrials.gov: NCT03310645 (initial registration: 16 October, 2017).